Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-02 Sale |
2022-06-03 4:13 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
1,355 | $0.06 | $81 | 75,388 (Direct) |
View |
2022-06-02 Sale |
2022-06-03 4:12 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer |
1,578 | $0.06 | $95 | 89,027 (Direct) |
View |
2022-06-02 Sale |
2022-06-03 4:11 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
4,023 | $0.06 | $241 | 304,377 (Direct) |
View |
2022-06-01 Sale |
2022-06-02 4:32 pm |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
2,500 | $0.0601 | $150 | 43,000 (Direct) |
View |
2022-05-31 Sale |
2022-06-02 4:31 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
117,244 | $0.0617 | $7,234 | 308,400 (Direct) |
View |
2022-05-27 Sale |
2022-06-01 4:11 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Siber George Director |
20,425 | $0.0653 | $1,334 | 252 (Direct) |
View |
2022-05-24 Sale |
2022-05-26 6:32 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Walker Paul Edward 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-24 Sale |
2022-05-26 6:31 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Sonsini Peter W. 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-24 Sale |
2022-05-26 6:29 pm |
GENOCEA BIOSCIENCES INC. | GNCA | SANDELL SCOTT D 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-24 Sale |
2022-05-26 6:26 pm |
GENOCEA BIOSCIENCES INC. | GNCA | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Direct) |
View |
2022-05-24 Sale |
2022-05-26 6:25 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Makhzoumi Mohamad 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-24 Sale |
2022-05-26 6:23 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Florence Anthony A. Jr. 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-24 Sale |
2022-05-26 6:21 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Chang Carmen 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-24 Sale |
2022-05-26 6:19 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-24 Sale |
2022-05-26 6:16 pm |
GENOCEA BIOSCIENCES INC. | GNCA | BASKETT FOREST 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
2022-05-25 Sale |
2022-05-26 4:15 pm |
GENOCEA BIOSCIENCES INC. | GNCA | STAPLETON RAYMOND D JR CHIEF TECHNOLOGY OFFICER |
2,500 | $0.089 | $223 | 43,750 (Direct) |
View |
2022-05-25 Sale |
2022-05-26 4:13 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer |
16,525 | $0.0881 | $1,456 | 90,605 (Direct) |
View |
2022-05-26 Sale |
2022-05-26 4:11 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
24,407 | $0.0765 | $1,867 | 76,743 (Direct) |
View |
2022-04-04 Sale |
2022-04-05 08:18 am |
GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer |
1,212 | $1.25 | $1,515 | 96,193 (Direct) |
View |
2022-04-04 Sale |
2022-04-05 08:17 am |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
963 | $1.25 | $1,204 | 91,775 (Direct) |
View |
2022-04-04 Sale |
2022-04-05 08:17 am |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
1,091 | $1.25 | $1,364 | 68,330 (Direct) |
View |
2022-04-04 Sale |
2022-04-05 08:15 am |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
3,924 | $1.25 | $4,905 | 369,487 (Direct) |
View |
2022-04-04 Sale |
2022-04-05 08:13 am |
GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER |
963 | $1.25 | $1,204 | 74,459 (Direct) |
View |
2022-03-16 Sale |
2022-03-17 4:12 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer |
3,349 | $1.1 | $3,684 | 228,655 (Direct) |
View |
2022-03-16 Sale |
2022-03-17 4:11 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
2,873 | $1.1 | $3,160 | 205,238 (Direct) |
View |
2022-03-16 Sale |
2022-03-17 4:09 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
2,717 | $1.1 | $2,989 | 163,171 (Direct) |
View |
2022-03-16 Sale |
2022-03-17 4:06 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
11,435 | $1.1 | $12,579 | 823,411 (Direct) |
View |
2022-03-16 Sale |
2022-03-17 4:04 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER |
2,397 | $1.1 | $2,637 | 169,172 (Direct) |
View |
2021-04-02 Sale |
2022-03-16 5:32 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer |
1,809 | $2.5394 | $4,594 | 67,941 (Direct) |
View |
2021-04-02 Sale |
2022-03-16 5:31 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
1,436 | $2.5392 | $3,646 | 62,486 (Direct) |
View |
2021-04-02 Sale |
2022-03-16 5:29 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
1,472 | $2.5391 | $3,738 | 48,700 (Direct) |
View |
2021-04-02 Sale |
2022-03-16 5:28 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
5,874 | $2.54 | $14,920 | 286,003 (Direct) |
View |
2021-04-02 Sale |
2022-03-16 5:25 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER |
1,436 | $2.5392 | $3,646 | 51,881 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-03-15 Option Award |
2022-03-17 4:17 pm |
N/A 2022-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
150,000 | $0 | 158,000 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 4:14 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | STAPLETON RAYMOND D JR CHIEF TECHNOLOGY OFFICER |
175,000 | $0 | 177,500 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 4:12 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer |
175,000 | $0 | 228,655 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 4:11 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
150,000 | $0 | 205,238 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 4:09 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
125,000 | $0 | 163,171 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 4:06 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
600,000 | $0 | 823,411 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 4:04 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER |
125,000 | $0 | 169,172 (Direct) |
View |
2022-03-03 Option Award |
2022-03-07 6:14 pm |
N/A 2032-03-03 |
GENOCEA BIOSCIENCES INC. | GNCA | Lunger John Director |
30,000 | $0 | 30,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-28 4:02 pm |
N/A 2031-09-09 |
GENOCEA BIOSCIENCES INC. | GNCA | Herron Jennifer Lyn Director |
30,000 | $0 | 30,000 (Direct) |
View |
2021-07-01 Option Award |
2021-07-02 4:27 pm |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |